| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
35,410,000 |
| Market
Cap: |
14.02(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$197.54 - $413.31 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 463 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
34 |
| Total Shares Sold |
1,742,072 |
2,404,472 |
3,519,952 |
3,608,378 |
| Total Sell Value |
$699,894,249 |
$883,563,199 |
$1,155,800,595 |
$1,175,475,107 |
| Total People Sold |
6 |
6 |
8 |
8 |
| Total Sell Transactions |
39 |
65 |
82 |
89 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Troendle August J. |
President & CEO |
• • • |
2020-12-28 |
4 |
AS |
$140.00 |
$192,360 |
I/I |
(1,374) |
6,513,797 |
|
20% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2020-12-24 |
4 |
AS |
$140.00 |
$536,060 |
D/D |
(3,829) |
6,515,171 |
|
18% |
|
| Troendle August J. |
President & CEO |
• • • |
2020-12-24 |
4 |
AS |
$140.00 |
$536,060 |
I/I |
(3,829) |
6,515,171 |
|
18% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2020-12-23 |
4 |
AS |
$140.11 |
$496,970 |
D/D |
(3,547) |
6,519,000 |
|
18% |
|
| Troendle August J. |
President & CEO |
• • • |
2020-12-23 |
4 |
OE |
$54.74 |
$2,189,600 |
D/D |
40,000 |
706,643 |
|
- |
|
| Troendle August J. |
President & CEO |
• • • |
2020-12-23 |
4 |
AS |
$140.11 |
$496,970 |
I/I |
(3,547) |
6,519,000 |
|
18% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2020-12-22 |
4 |
AS |
$140.01 |
$4,656,733 |
D/D |
(33,260) |
6,522,547 |
|
18% |
|
| Troendle August J. |
President & CEO |
• • • |
2020-12-22 |
4 |
AS |
$140.01 |
$4,656,733 |
I/I |
(33,260) |
6,522,547 |
|
18% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2020-12-18 |
4 |
AS |
$141.85 |
$30,646,409 |
D/D |
(216,048) |
6,555,807 |
|
21% |
|
| Troendle August J. |
President & CEO |
• • • |
2020-12-18 |
4 |
AS |
$141.85 |
$30,646,409 |
I/I |
(216,048) |
6,555,807 |
|
21% |
|
| Geiger Jesse J |
CFO & COO, Lab Operations |
• – – |
2020-12-14 |
4 |
S |
$142.00 |
$596,400 |
D/D |
(4,200) |
6,382 |
|
-38% |
|
| Geiger Jesse J |
CFO & COO, Lab Operations |
• – – |
2020-12-14 |
4 |
OE |
$23.00 |
$96,600 |
D/D |
4,200 |
10,582 |
|
- |
|
| Ewald Stephen P |
General Counsel & Corp. Secy. |
• – – |
2020-12-10 |
4 |
S |
$140.07 |
$1,400,700 |
D/D |
(10,000) |
13,854 |
|
-34% |
|
| Ewald Stephen P |
General Counsel & Corp. Secy. |
• – – |
2020-12-10 |
4 |
OE |
$90.65 |
$906,500 |
D/D |
10,000 |
23,854 |
|
- |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2020-12-01 |
4 |
AS |
$130.86 |
$1,832,040 |
D/D |
(14,000) |
6,771,855 |
|
36% |
|
| Troendle August J. |
President & CEO |
• • • |
2020-12-01 |
4 |
AS |
$130.86 |
$1,832,040 |
I/I |
(14,000) |
6,771,855 |
|
36% |
|
| Ewald Stephen P |
General Counsel & Corp. Secy. |
• – – |
2020-11-06 |
4 |
OE |
$14.41 |
$151,564 |
D/D |
10,518 |
13,854 |
|
- |
|
| Burwig Susan E |
Exec. VP, Operations |
• – – |
2020-11-06 |
4 |
OE |
$14.41 |
$245,503 |
D/D |
17,037 |
76,216 |
|
- |
|
| Burwig Susan E |
Exec. VP, Operations |
• – – |
2020-10-08 |
4 |
OE |
$14.41 |
$288,200 |
D/D |
20,000 |
59,179 |
|
- |
|
| Troendle August J. |
President & CEO |
• • • |
2020-10-06 |
4 |
OE |
$23.00 |
$1,150,000 |
D/D |
50,000 |
666,643 |
|
- |
|
| Troendle August J. |
President & CEO |
• • • |
2020-10-05 |
4 |
OE |
$14.41 |
$68,663 |
I/I |
4,443 |
6,785,855 |
|
- |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2020-10-05 |
4 |
OE |
$14.41 |
$68,663 |
D/D |
4,443 |
6,785,855 |
|
- |
|
247 Records found
|
|
Page 10 of 10 |
|
|
6.16 (1.58%) 
